Literature DB >> 25189475

US signs contract with ZMapp maker to accelerate development of the Ebola drug.

Michael McCarthy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25189475     DOI： 10.1136/bmj.g5488

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

1.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Authors:  Edgar Davidson; Christopher Bryan; Rachel H Fong; Trevor Barnes; Jennifer M Pfaff; Manu Mabila; Joseph B Rucker; Benjamin J Doranz
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs.

Authors:  Mable Chan; Frederick W Holtsberg; Hong Vu; Katie A Howell; Anders Leung; Evelyn Van der Hart; Paul H Walz; M Javad Aman; Shantha Kodihalli; Darwyn Kobasa
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 3.  Ebola virus disease.

Authors:  Nicholas J Beeching; Manuel Fenech; Catherine F Houlihan
Journal:  BMJ       Date:  2014-12-10

Review 4.  Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak.

Authors:  Gary Wong; Gary P Kobinger
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 5.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 6.  Molecular pharming's foot in the FDA's door: Protalix's trailblazing story.

Authors:  Tsafrir S Mor
Journal:  Biotechnol Lett       Date:  2015-07-07       Impact factor: 2.461

7.  Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.

Authors:  Robert W Cross; Chad E Mire; Luis M Branco; Joan B Geisbert; Megan M Rowland; Megan L Heinrich; Augustine Goba; Mambu Momoh; Donald S Grant; Mohamed Fullah; Sheik Humarr Khan; James E Robinson; Thomas W Geisbert; Robert F Garry
Journal:  Antiviral Res       Date:  2016-08-13       Impact factor: 5.970

8.  Ebola virus disease: What clinicians in the United States need to know.

Authors:  William A Fischer; Timothy M Uyeki; Robert V Tauxe
Journal:  Am J Infect Control       Date:  2015-06-24       Impact factor: 2.918

Review 9.  Ebola: translational science considerations.

Authors:  Francesco Chiappelli; Andre Bakhordarian; April D Thames; Angela M Du; Allison L Jan; Melissa Nahcivan; Mia T Nguyen; Nateli Sama; Ercolano Manfrini; Francesco Piva; Rafael Malagoli Rocha; Carl A Maida
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

10.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.